News

Chemours is at a cyclical low, presenting a buying opportunity ahead of expected 2Q25 revenue growth. Click here to read an ...
Shares of Chemours rose after the company agreed to a settlement with the state of New Jersey to resolve environmental and contamination claims involving PFAS, also known as forever chemicals. The ...
Analysts estimate that Chemours will report an earnings per share (EPS) of $0.46. Anticipation surrounds Chemours's ...
The Chemours Company ("Chemours" or "the Company") (NYSE: CC) today announced that the Company expects to issue its second quarter 2025 financial results after market on Tuesday, August 5, 2025.